Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Mynarek

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Cancers|February 15, 2022
Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 StudyChristine Gaab, Jonas E Adolph, Stephan Tippelt, et al.
Cancers|June 19, 2024
Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time IrradiationJonas E Adolph, Gudrun Fleischhack, Sebastian Tschirner, et al.
Neuro-Oncology|April 28, 2021
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trialB-Ole Juhnke, Marco Gessi, Nicolas U Gerber, et al.
Neuro-Oncology Advances|December 23, 2024
Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: Results from the HIT-MED databaseLara Engertsberger, Martin Benesch, Martin Mynarek, et al.
Acta Neuropathologica Communications|July 27, 2023
Mitochondrial DNA mutations in MedulloblastomaViktoria L E Funke, Sarah Sandmann, Viktoria Melcher, et al.
Acta Neuropathologica|January 22, 2021
Supratentorial ependymoma in childhood: more than just RELA or YAPValentina Zschernack, Stephanie T Jünger, Martin Mynarek, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 23, 2020
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trialStefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
Journal of Translational Medicine|June 5, 2023
Group-specific cellular metabolism in MedulloblastomaViktoria L E Funke, Carolin Walter, Viktoria Melcher, et al.
Acta Neuropathologica|May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypesTanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 5, 2021
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trialStefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Cancers|February 15, 2022
Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 StudyChristine Gaab, Jonas E Adolph, Stephan Tippelt, et al.
Cancers|June 19, 2024
Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time IrradiationJonas E Adolph, Gudrun Fleischhack, Sebastian Tschirner, et al.
Neuro-Oncology|April 28, 2021
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trialB-Ole Juhnke, Marco Gessi, Nicolas U Gerber, et al.
Neuro-Oncology Advances|December 23, 2024
Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: Results from the HIT-MED databaseLara Engertsberger, Martin Benesch, Martin Mynarek, et al.
Acta Neuropathologica Communications|July 27, 2023
Mitochondrial DNA mutations in MedulloblastomaViktoria L E Funke, Sarah Sandmann, Viktoria Melcher, et al.
Acta Neuropathologica|January 22, 2021
Supratentorial ependymoma in childhood: more than just RELA or YAPValentina Zschernack, Stephanie T Jünger, Martin Mynarek, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 23, 2020
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trialStefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
Journal of Translational Medicine|June 5, 2023
Group-specific cellular metabolism in MedulloblastomaViktoria L E Funke, Carolin Walter, Viktoria Melcher, et al.
Acta Neuropathologica|May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypesTanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 5, 2021
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trialStefan Dietzsch, Annett Braesigk, Clemens Seidel, et al.
Pageof 10